Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease.
about
Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson's diseaseNeuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease.Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's diseaseOlfaction in Parkinson's disease and related disorders.Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease.Dietary flavonoid intake and risk of incident depression in midlife and older women.Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease.Selective MAO-B inhibitors: a lesson from natural products.Ellagic Acid Protects the Brain Against 6-Hydroxydopamine Induced Neuroinflammation in a Rat Model of Parkinson's Disease.Atorvastatin Prevents Early Oxidative Events and Modulates Inflammatory Mediators in the Striatum Following Intranasal 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Administration in Rats.Neuroprotective effect of the proanthocyanidin-rich fraction in experimental model of spinal cord injury.Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism.Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease.Parkin-knockout mice did not display increased vulnerability to intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).Plant-Derived Natural Products for Parkinson's Disease Therapy.Neuroprotective Effects of Proanthocyanidins, Natural Flavonoids Derived From Plants, on Rotenone-Induced Oxidative Stress and Apoptotic Cell Death in Human Neuroblastoma SH-SY5Y Cells.Polyphenols in Parkinson's Disease: A Systematic Review of In Vivo Studies.
P2860
Q33606408-80351FE8-401D-4A90-BF0A-408DDCCC7816Q33625539-8F5A59DF-2735-4E4F-9193-58CD0668962EQ34654923-DD5B8CF3-5968-433E-AEDC-E5FF1875C7F4Q36193915-2079372B-4C92-4180-BF8D-C1B27B20BAE1Q36202527-F71161C0-1964-4F45-A36E-C9CF6059153BQ37202419-DF352C15-BAB6-46B0-BEF6-3D1F93F63127Q37946305-3585A53F-01A2-4473-8208-D7D8298EB5A2Q38046734-A650B8F9-C33A-4098-87D4-B444A2E09D35Q38161850-4DA22C50-F48B-465F-BEC6-E462E16EEECDQ42152168-B66D46D7-5CB2-406F-8081-0E5850487986Q46256354-6BF540FD-D133-4B9D-B843-13834CF2750DQ46944871-D92E4BF6-08BF-4999-92DE-6435A4A0CE12Q48078497-B757827D-1714-4AFF-B119-42A03362A710Q48200129-EA5532A7-6E3B-4BCB-B2E0-0B6B19575B8CQ50235339-9A041578-856E-4126-B162-1153390077F0Q51020610-D6C8F057-2D0A-45A5-B4C5-21FA25CC2AD1Q51066799-D5A769B9-842D-49C9-9D57-18873B028D90Q51800931-2D7B8D10-EA35-4C03-A0A2-C9B7D7636939Q55265085-2BFC70D8-5D8F-4AFA-9F8E-26C186557173Q55384361-05DE87D5-8209-40CF-B42A-EFF7AE9C2C3D
P2860
Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Proanthocyanidin-rich fraction ...... model of Parkinson's disease.
@en
Proanthocyanidin-rich fraction ...... model of Parkinson's disease.
@nl
type
label
Proanthocyanidin-rich fraction ...... model of Parkinson's disease.
@en
Proanthocyanidin-rich fraction ...... model of Parkinson's disease.
@nl
prefLabel
Proanthocyanidin-rich fraction ...... model of Parkinson's disease.
@en
Proanthocyanidin-rich fraction ...... model of Parkinson's disease.
@nl
P2093
P2860
P50
P1476
Proanthocyanidin-rich fraction ...... t model of Parkinson's disease
@en
P2093
Aderbal S Aguiar
Andreza F De Bem
Eduardo L G Moreira
Francielle V Pinheiro
Heros Horst
Jade de Oliveira
Jarbas M Siqueira
Jardel G Villarinho
José Marino-Neto
Juliano Ferreira
P2860
P2888
P304
P356
10.1007/S00702-010-0464-X
P577
2010-10-08T00:00:00Z
P5875
P6179
1023713726